柳氮磺吡啶致结晶尿引发严重急性肾损伤
本文报告一例72岁克罗恩病患者,长期使用柳氮磺吡啶超过10年,出现严重急性肾损伤(血肌酐9.7mg/dL),肾超声见结石,自行排出大量由柳氮磺吡啶代谢物组成的结石。停用柳氮磺吡啶并静脉补液后结石清除,血肌酐降至3.1mg/dL,肾功能最终恢复至基线。提示柳氮磺吡啶相关肾结石可能被低估,水化状态可能起重要作用。
要点
- 长期使用柳氮磺吡啶者出现急性肾损伤需警惕药物性结晶尿与肾结石。
- 本例停用柳氮磺吡啶并静脉补液后血肌酐由9.7mg/dL降至3.1mg/dL并恢复至基线。
- 水化状态可能是柳氮磺吡啶相关结晶尿与结石形成的重要影响因素。
核心结论
- 柳氮磺吡啶相关肾并发症(尤其肾结石)在炎症性肠病患者中可能被低估,但可能很严重。
研究设计与样本
- 个案报告:一例72岁克罗恩病男性患者,使用柳氮磺吡啶超过10年。
主要发现
- 患者表现为严重急性肾损伤,血肌酐9.7mg/dL,肾超声见结石,并自行排出大量由柳氮磺吡啶代谢物组成的结石。
- 停用柳氮磺吡啶并静脉补液后结石清除,血肌酐改善至3.1mg/dL,肾功能最终恢复至基线。
临床怎么用
- 对长期使用柳氮磺吡啶的炎症性肠病患者,出现肾功能异常时应考虑药物相关结晶尿与肾结石,并及时停药与补液。
局限性
- 为单个病例报告,因果推断与普遍性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sulfasalazine is an anti-inflammatory agent commonly used in the treatment of autoimmune conditions such as inflammatory bowel disease and rheumatoid arthritis. Sulfasalazine is converted by gut bacteria into sulfapyridine and the clinically active metabolite 5-aminosalicylic acid (5-ASA), and its efficacy is proportional to the 5-ASA concentration within the intestinal lumen. Renal complications are commonly reported for the chemically similar 5-ASA derivative mesalamine, but are not well-known side effects of sulfasalazine therapy. We report a 72-year-old patient with Crohn's disease managed with sulfasalazine for more than 10 years who presented with severe acute kidney injury (serum creatinine, 9.7mg/dL). Renal ultrasound revealed calculi and he subsequently spontaneously voided innumerable stones, which were composed of sulfasalazine metabolites. His renal calculi cleared and serum creatinine concentration improved to 3.1mg/dL after discontinuing sulfasalazine therapy and intravenous fluid hydration. His kidney function eventually returned to baseline. This case demonstrates that renal complications, in particular nephrolithiasis, may be an under-reported but potentially serious phenomenon in patients with inflammatory bowel disease treated with sulfasalazine and that their hydration status may play an important role in this process.
引用
- Durando M, Tiu H, Kim JS, et al. Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury. Am J Kidney Dis. 2017. PMID: 28669550. doi:10.1053/j.ajkd.2017.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。